New Brunswick-based Johnson & Johnson halts COVID-19 vaccine trial after unexpected illness

A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company probes whether a study participant’s unexplained illness is related to the shot.

More Stories

00:33

US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case

Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19

00:21

Biden administration announces $600M to produce COVID tests and will reopen website to order them

Murphy administration: No plans to implement any COVID-19 restrictions

00:39

Cape May hospital asking patients to wear mask amid COVID surge

02:57

Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes